nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—PTGS2—obesity	0.375	1	CbGaD
Aminosalicylic Acid—Soft stools—Orlistat—obesity	0.0298	0.138	CcSEcCtD
Aminosalicylic Acid—PTGS2—ovarian follicle—obesity	0.0101	0.119	CbGeAlD
Aminosalicylic Acid—CHUK—cardiovascular system—obesity	0.00474	0.0555	CbGeAlD
Aminosalicylic Acid—CHUK—adipose tissue—obesity	0.00418	0.0489	CbGeAlD
Aminosalicylic Acid—CHUK—digestive system—obesity	0.00393	0.046	CbGeAlD
Aminosalicylic Acid—CHUK—adrenal gland—obesity	0.00375	0.0439	CbGeAlD
Aminosalicylic Acid—ALOX5—islet of Langerhans—obesity	0.00369	0.0432	CbGeAlD
Aminosalicylic Acid—ALOX5—respiratory system—obesity	0.00349	0.0408	CbGeAlD
Aminosalicylic Acid—Eruption—Sibutramine—obesity	0.00338	0.0157	CcSEcCtD
Aminosalicylic Acid—Hypothyroidism—Orlistat—obesity	0.00335	0.0155	CcSEcCtD
Aminosalicylic Acid—CHUK—endocrine gland—obesity	0.00325	0.038	CbGeAlD
Aminosalicylic Acid—Hypothyroidism—Sibutramine—obesity	0.00324	0.015	CcSEcCtD
Aminosalicylic Acid—Dermatitis exfoliative—Cimetidine—obesity	0.00299	0.0139	CcSEcCtD
Aminosalicylic Acid—MPO—respiratory system—obesity	0.00295	0.0345	CbGeAlD
Aminosalicylic Acid—CHUK—liver—obesity	0.00293	0.0343	CbGeAlD
Aminosalicylic Acid—ALOX5—cardiovascular system—obesity	0.00267	0.0312	CbGeAlD
Aminosalicylic Acid—Dermatitis atopic—Bupropion—obesity	0.00245	0.0114	CcSEcCtD
Aminosalicylic Acid—ALOX5—adipose tissue—obesity	0.00235	0.0276	CbGeAlD
Aminosalicylic Acid—MPO—cardiovascular system—obesity	0.00226	0.0264	CbGeAlD
Aminosalicylic Acid—ALOX5—digestive system—obesity	0.00222	0.0259	CbGeAlD
Aminosalicylic Acid—PTGS2—gall bladder—obesity	0.00216	0.0253	CbGeAlD
Aminosalicylic Acid—Anorexia—Benzphetamine—obesity	0.00215	0.00995	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Diethylpropion—obesity	0.00213	0.0099	CcSEcCtD
Aminosalicylic Acid—ALOX5—adrenal gland—obesity	0.00211	0.0247	CbGeAlD
Aminosalicylic Acid—Agranulocytosis—Cimetidine—obesity	0.00203	0.00942	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Methamphetamine—obesity	0.00202	0.00934	CcSEcCtD
Aminosalicylic Acid—MPO—pituitary gland—obesity	0.002	0.0234	CbGeAlD
Aminosalicylic Acid—Decreased appetite—Benzphetamine—obesity	0.00196	0.00907	CcSEcCtD
Aminosalicylic Acid—Anorexia—Phendimetrazine—obesity	0.00196	0.00907	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Cimetidine—obesity	0.00195	0.00906	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Benzphetamine—obesity	0.00194	0.00901	CcSEcCtD
Aminosalicylic Acid—MPO—digestive system—obesity	0.00187	0.0219	CbGeAlD
Aminosalicylic Acid—Urticaria—Methamphetamine—obesity	0.00185	0.0086	CcSEcCtD
Aminosalicylic Acid—ALOX5—endocrine gland—obesity	0.00183	0.0214	CbGeAlD
Aminosalicylic Acid—Encephalopathy—Topiramate—obesity	0.0018	0.00834	CcSEcCtD
Aminosalicylic Acid—Urticaria—Benzphetamine—obesity	0.00179	0.00829	CcSEcCtD
Aminosalicylic Acid—MPO—adrenal gland—obesity	0.00179	0.0209	CbGeAlD
Aminosalicylic Acid—Decreased appetite—Phendimetrazine—obesity	0.00178	0.00827	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Methamphetamine—obesity	0.00172	0.00797	CcSEcCtD
Aminosalicylic Acid—Vascular purpura—Sibutramine—obesity	0.00169	0.00782	CcSEcCtD
Aminosalicylic Acid—Flatulence—Cimetidine—obesity	0.00168	0.00777	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Benzphetamine—obesity	0.00166	0.00769	CcSEcCtD
Aminosalicylic Acid—ALOX5—liver—obesity	0.00165	0.0193	CbGeAlD
Aminosalicylic Acid—Abdominal pain—Phendimetrazine—obesity	0.00162	0.00752	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Diethylpropion—obesity	0.0016	0.00742	CcSEcCtD
Aminosalicylic Acid—Hypoglycaemia—Orlistat—obesity	0.0016	0.00741	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Methamphetamine—obesity	0.0016	0.00741	CcSEcCtD
Aminosalicylic Acid—Methyldopa—COMT—obesity	0.00157	0.187	CrCbGaD
Aminosalicylic Acid—Purpura—Sibutramine—obesity	0.00157	0.00726	CcSEcCtD
Aminosalicylic Acid—Dermatitis atopic—Topiramate—obesity	0.00156	0.00723	CcSEcCtD
Aminosalicylic Acid—MPO—endocrine gland—obesity	0.00155	0.0181	CbGeAlD
Aminosalicylic Acid—Hypoglycaemia—Sibutramine—obesity	0.00155	0.00717	CcSEcCtD
Aminosalicylic Acid—Dizziness—Methamphetamine—obesity	0.00154	0.00716	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Benzphetamine—obesity	0.00154	0.00714	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Cimetidine—obesity	0.00152	0.00706	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Sibutramine—obesity	0.00151	0.007	CcSEcCtD
Aminosalicylic Acid—Dizziness—Benzphetamine—obesity	0.00149	0.0069	CcSEcCtD
Aminosalicylic Acid—Headache—Methamphetamine—obesity	0.00146	0.00678	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Phentermine—obesity	0.00145	0.00671	CcSEcCtD
Aminosalicylic Acid—PTGS2—islet of Langerhans—obesity	0.00142	0.0166	CbGeAlD
Aminosalicylic Acid—Headache—Benzphetamine—obesity	0.00141	0.00654	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Phendimetrazine—obesity	0.0014	0.00651	CcSEcCtD
Aminosalicylic Acid—PTGS1—respiratory system—obesity	0.0014	0.0164	CbGeAlD
Aminosalicylic Acid—MPO—liver—obesity	0.0014	0.0163	CbGeAlD
Aminosalicylic Acid—Dermatitis exfoliative—Bupropion—obesity	0.00139	0.00647	CcSEcCtD
Aminosalicylic Acid—Droxidopa—ADRB3—obesity	0.00138	0.165	CrCbGaD
Aminosalicylic Acid—Thrombocytopenia—Cimetidine—obesity	0.00136	0.0063	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Orlistat—obesity	0.00136	0.00629	CcSEcCtD
Aminosalicylic Acid—Dizziness—Phendimetrazine—obesity	0.00136	0.00629	CcSEcCtD
Aminosalicylic Acid—Hypoglycaemia—Bupropion—obesity	0.00135	0.00625	CcSEcCtD
Aminosalicylic Acid—PTGS2—respiratory system—obesity	0.00134	0.0157	CbGeAlD
Aminosalicylic Acid—Nausea—Benzphetamine—obesity	0.00134	0.0062	CcSEcCtD
Aminosalicylic Acid—Urticaria—Phentermine—obesity	0.00133	0.00618	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Phentermine—obesity	0.00133	0.00615	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Bupropion—obesity	0.00132	0.0061	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Sibutramine—obesity	0.00131	0.00609	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Phenylpropanolamine—obesity	0.00129	0.00599	CcSEcCtD
Aminosalicylic Acid—Headache—Phendimetrazine—obesity	0.00129	0.00596	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Diethylpropion—obesity	0.00126	0.00584	CcSEcCtD
Aminosalicylic Acid—Nausea—Phendimetrazine—obesity	0.00122	0.00565	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Orlistat—obesity	0.00118	0.00546	CcSEcCtD
Aminosalicylic Acid—Urticaria—Diethylpropion—obesity	0.00116	0.00537	CcSEcCtD
Aminosalicylic Acid—Dizziness—Phenylpropanolamine—obesity	0.00116	0.00537	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Phentermine—obesity	0.00115	0.00532	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Bupropion—obesity	0.00114	0.00531	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Sibutramine—obesity	0.00114	0.00529	CcSEcCtD
Aminosalicylic Acid—PTGS2—adrenal cortex—obesity	0.00112	0.0131	CbGeAlD
Aminosalicylic Acid—Vomiting—Phenylpropanolamine—obesity	0.00111	0.00517	CcSEcCtD
Aminosalicylic Acid—Dizziness—Phentermine—obesity	0.00111	0.00514	CcSEcCtD
Aminosalicylic Acid—Rash—Phenylpropanolamine—obesity	0.0011	0.00512	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Phenylpropanolamine—obesity	0.0011	0.00512	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Cimetidine—obesity	0.0011	0.00509	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Orlistat—obesity	0.00108	0.005	CcSEcCtD
Aminosalicylic Acid—PTGS1—cardiovascular system—obesity	0.00107	0.0125	CbGeAlD
Aminosalicylic Acid—Vomiting—Phentermine—obesity	0.00107	0.00494	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Orlistat—obesity	0.00107	0.00494	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Orlistat—obesity	0.00106	0.0049	CcSEcCtD
Aminosalicylic Acid—Rash—Phentermine—obesity	0.00106	0.0049	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Phentermine—obesity	0.00106	0.0049	CcSEcCtD
Aminosalicylic Acid—Headache—Phentermine—obesity	0.00105	0.00487	CcSEcCtD
Aminosalicylic Acid—Nausea—Phenylpropanolamine—obesity	0.00104	0.00483	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Bupropion—obesity	0.00103	0.00477	CcSEcCtD
Aminosalicylic Acid—PTGS2—cardiovascular system—obesity	0.00102	0.012	CbGeAlD
Aminosalicylic Acid—Hypersensitivity—Cimetidine—obesity	0.00102	0.00474	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Diethylpropion—obesity	0.000998	0.00463	CcSEcCtD
Aminosalicylic Acid—Nausea—Phentermine—obesity	0.000996	0.00462	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Bupropion—obesity	0.000994	0.00461	CcSEcCtD
Aminosalicylic Acid—Jaundice—Bupropion—obesity	0.000988	0.00458	CcSEcCtD
Aminosalicylic Acid—Dizziness—Diethylpropion—obesity	0.000965	0.00447	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Cimetidine—obesity	0.00095	0.0044	CcSEcCtD
Aminosalicylic Acid—PTGS1—pituitary gland—obesity	0.000949	0.0111	CbGeAlD
Aminosalicylic Acid—PTGS1—adipose tissue—obesity	0.000945	0.0111	CbGeAlD
Aminosalicylic Acid—Malnutrition—Orlistat—obesity	0.000939	0.00435	CcSEcCtD
Aminosalicylic Acid—Vascular purpura—Topiramate—obesity	0.000937	0.00434	CcSEcCtD
Aminosalicylic Acid—Vomiting—Diethylpropion—obesity	0.000928	0.0043	CcSEcCtD
Aminosalicylic Acid—Flatulence—Orlistat—obesity	0.000925	0.00429	CcSEcCtD
Aminosalicylic Acid—Rash—Diethylpropion—obesity	0.00092	0.00427	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Orlistat—obesity	0.000919	0.00426	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Diethylpropion—obesity	0.000919	0.00426	CcSEcCtD
Aminosalicylic Acid—Dizziness—Cimetidine—obesity	0.000918	0.00426	CcSEcCtD
Aminosalicylic Acid—Headache—Diethylpropion—obesity	0.000914	0.00424	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Bupropion—obesity	0.00091	0.00422	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Sibutramine—obesity	0.000909	0.00421	CcSEcCtD
Aminosalicylic Acid—PTGS2—pituitary gland—obesity	0.000907	0.0106	CbGeAlD
Aminosalicylic Acid—PTGS2—adipose tissue—obesity	0.000903	0.0106	CbGeAlD
Aminosalicylic Acid—Urinary tract disorder—Bupropion—obesity	0.000899	0.00417	CcSEcCtD
Aminosalicylic Acid—Flatulence—Sibutramine—obesity	0.000895	0.00415	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Bupropion—obesity	0.000892	0.00414	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Sibutramine—obesity	0.00089	0.00413	CcSEcCtD
Aminosalicylic Acid—PTGS1—digestive system—obesity	0.000889	0.0104	CbGeAlD
Aminosalicylic Acid—Vomiting—Cimetidine—obesity	0.000883	0.00409	CcSEcCtD
Aminosalicylic Acid—Mesalazine—PPARG—obesity	0.000882	0.105	CrCbGaD
Aminosalicylic Acid—Rash—Cimetidine—obesity	0.000875	0.00406	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Cimetidine—obesity	0.000874	0.00405	CcSEcCtD
Aminosalicylic Acid—Headache—Cimetidine—obesity	0.00087	0.00403	CcSEcCtD
Aminosalicylic Acid—Purpura—Topiramate—obesity	0.00087	0.00403	CcSEcCtD
Aminosalicylic Acid—Nausea—Diethylpropion—obesity	0.000867	0.00402	CcSEcCtD
Aminosalicylic Acid—Hypoglycaemia—Topiramate—obesity	0.000859	0.00398	CcSEcCtD
Aminosalicylic Acid—PTGS2—digestive system—obesity	0.00085	0.00995	CbGeAlD
Aminosalicylic Acid—PTGS1—adrenal gland—obesity	0.000848	0.00992	CbGeAlD
Aminosalicylic Acid—Anaemia—Sibutramine—obesity	0.00084	0.0039	CcSEcCtD
Aminosalicylic Acid—Nausea—Cimetidine—obesity	0.000824	0.00382	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Sibutramine—obesity	0.000813	0.00377	CcSEcCtD
Aminosalicylic Acid—PTGS2—adrenal gland—obesity	0.00081	0.00948	CbGeAlD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000794	0.00368	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Bupropion—obesity	0.000792	0.00367	CcSEcCtD
Aminosalicylic Acid—Flatulence—Bupropion—obesity	0.000781	0.00362	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Bupropion—obesity	0.000776	0.0036	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Orlistat—obesity	0.000752	0.00349	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Orlistat—obesity	0.000744	0.00345	CcSEcCtD
Aminosalicylic Acid—PTGS1—endocrine gland—obesity	0.000735	0.0086	CbGeAlD
Aminosalicylic Acid—Anaemia—Bupropion—obesity	0.000732	0.0034	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Topiramate—obesity	0.000729	0.00338	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Sibutramine—obesity	0.000726	0.00337	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Sibutramine—obesity	0.00072	0.00334	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Bupropion—obesity	0.000709	0.00329	CcSEcCtD
Aminosalicylic Acid—Anorexia—Sibutramine—obesity	0.000707	0.00328	CcSEcCtD
Aminosalicylic Acid—PTGS2—endocrine gland—obesity	0.000702	0.00822	CbGeAlD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.00067	0.00311	CcSEcCtD
Aminosalicylic Acid—L-DOPA—DRD4—obesity	0.000667	0.0797	CrCbGaD
Aminosalicylic Acid—Decreased appetite—Orlistat—obesity	0.000666	0.00309	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Orlistat—obesity	0.000662	0.00307	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Topiramate—obesity	0.000655	0.00304	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Sibutramine—obesity	0.000645	0.00299	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Sibutramine—obesity	0.00064	0.00297	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Bupropion—obesity	0.000634	0.00294	CcSEcCtD
Aminosalicylic Acid—PTGS2—liver—obesity	0.000633	0.00741	CbGeAlD
Aminosalicylic Acid—Neuropathy peripheral—Topiramate—obesity	0.000633	0.00294	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Bupropion—obesity	0.000633	0.00294	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Bupropion—obesity	0.000628	0.00291	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Orlistat—obesity	0.000627	0.00291	CcSEcCtD
Aminosalicylic Acid—Droxidopa—ADRB1—obesity	0.000623	0.0744	CrCbGaD
Aminosalicylic Acid—Anorexia—Bupropion—obesity	0.000616	0.00286	CcSEcCtD
Aminosalicylic Acid—Urticaria—Orlistat—obesity	0.000609	0.00282	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Sibutramine—obesity	0.000606	0.00281	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Orlistat—obesity	0.000606	0.00281	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Orlistat—obesity	0.000606	0.00281	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Topiramate—obesity	0.000603	0.0028	CcSEcCtD
Aminosalicylic Acid—Urticaria—Sibutramine—obesity	0.000589	0.00273	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Sibutramine—obesity	0.000586	0.00272	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Sibutramine—obesity	0.000586	0.00272	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Topiramate—obesity	0.00058	0.00269	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Topiramate—obesity	0.000573	0.00266	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Topiramate—obesity	0.000568	0.00264	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Orlistat—obesity	0.000565	0.00262	CcSEcCtD
Aminosalicylic Acid—L-DOPA—DRD1—obesity	0.000565	0.0675	CrCbGaD
Aminosalicylic Acid—Decreased appetite—Bupropion—obesity	0.000562	0.00261	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Bupropion—obesity	0.000558	0.00259	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Sibutramine—obesity	0.000546	0.00253	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Bupropion—obesity	0.000529	0.00245	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Orlistat—obesity	0.000524	0.00243	CcSEcCtD
Aminosalicylic Acid—Droxidopa—ADRB2—obesity	0.000524	0.0626	CrCbGaD
Aminosalicylic Acid—Urticaria—Bupropion—obesity	0.000514	0.00238	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Bupropion—obesity	0.000511	0.00237	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Bupropion—obesity	0.000511	0.00237	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Sibutramine—obesity	0.000507	0.00235	CcSEcCtD
Aminosalicylic Acid—Dizziness—Orlistat—obesity	0.000507	0.00235	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Topiramate—obesity	0.000505	0.00234	CcSEcCtD
Aminosalicylic Acid—Flatulence—Topiramate—obesity	0.000497	0.00231	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Topiramate—obesity	0.000494	0.00229	CcSEcCtD
Aminosalicylic Acid—Dizziness—Sibutramine—obesity	0.00049	0.00227	CcSEcCtD
Aminosalicylic Acid—Vomiting—Orlistat—obesity	0.000487	0.00226	CcSEcCtD
Aminosalicylic Acid—Rash—Orlistat—obesity	0.000483	0.00224	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Orlistat—obesity	0.000483	0.00224	CcSEcCtD
Aminosalicylic Acid—Headache—Orlistat—obesity	0.00048	0.00223	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Bupropion—obesity	0.000476	0.00221	CcSEcCtD
Aminosalicylic Acid—Diflunisal—PTGS2—obesity	0.000474	0.0567	CrCbGaD
Aminosalicylic Acid—Vomiting—Sibutramine—obesity	0.000472	0.00219	CcSEcCtD
Aminosalicylic Acid—Rash—Sibutramine—obesity	0.000468	0.00217	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Sibutramine—obesity	0.000467	0.00217	CcSEcCtD
Aminosalicylic Acid—Anaemia—Topiramate—obesity	0.000466	0.00216	CcSEcCtD
Aminosalicylic Acid—Headache—Sibutramine—obesity	0.000465	0.00215	CcSEcCtD
Aminosalicylic Acid—Nausea—Orlistat—obesity	0.000455	0.00211	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Topiramate—obesity	0.000452	0.0021	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Bupropion—obesity	0.000442	0.00205	CcSEcCtD
Aminosalicylic Acid—Nausea—Sibutramine—obesity	0.000441	0.00204	CcSEcCtD
Aminosalicylic Acid—Dizziness—Bupropion—obesity	0.000428	0.00198	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000427	0.00198	CcSEcCtD
Aminosalicylic Acid—Diflunisal—ALB—obesity	0.000423	0.0505	CrCbGaD
Aminosalicylic Acid—Vomiting—Bupropion—obesity	0.000411	0.00191	CcSEcCtD
Aminosalicylic Acid—Rash—Bupropion—obesity	0.000408	0.00189	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Bupropion—obesity	0.000407	0.00189	CcSEcCtD
Aminosalicylic Acid—Headache—Bupropion—obesity	0.000405	0.00188	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Topiramate—obesity	0.000404	0.00187	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Topiramate—obesity	0.000403	0.00187	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Topiramate—obesity	0.0004	0.00186	CcSEcCtD
Aminosalicylic Acid—L-DOPA—DRD2—obesity	0.000398	0.0476	CrCbGaD
Aminosalicylic Acid—Anorexia—Topiramate—obesity	0.000393	0.00182	CcSEcCtD
Aminosalicylic Acid—Nausea—Bupropion—obesity	0.000384	0.00178	CcSEcCtD
Aminosalicylic Acid—Mesalazine—PTGS2—obesity	0.000372	0.0445	CrCbGaD
Aminosalicylic Acid—Decreased appetite—Topiramate—obesity	0.000358	0.00166	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Topiramate—obesity	0.000356	0.00165	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Topiramate—obesity	0.000337	0.00156	CcSEcCtD
Aminosalicylic Acid—Urticaria—Topiramate—obesity	0.000327	0.00152	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Topiramate—obesity	0.000326	0.00151	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Topiramate—obesity	0.000326	0.00151	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Topiramate—obesity	0.000303	0.00141	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Topiramate—obesity	0.000282	0.00131	CcSEcCtD
Aminosalicylic Acid—Dizziness—Topiramate—obesity	0.000272	0.00126	CcSEcCtD
Aminosalicylic Acid—Salicylic acid—PTGS2—obesity	0.000264	0.0315	CrCbGaD
Aminosalicylic Acid—Vomiting—Topiramate—obesity	0.000262	0.00121	CcSEcCtD
Aminosalicylic Acid—Rash—Topiramate—obesity	0.00026	0.0012	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Topiramate—obesity	0.000259	0.0012	CcSEcCtD
Aminosalicylic Acid—Headache—Topiramate—obesity	0.000258	0.0012	CcSEcCtD
Aminosalicylic Acid—Nausea—Topiramate—obesity	0.000245	0.00113	CcSEcCtD
Aminosalicylic Acid—Salicylic acid—ALB—obesity	0.000235	0.0281	CrCbGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TCF7L2—obesity	1.88e-05	5.96e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—NOS3—obesity	1.88e-05	5.95e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PIK3R1—obesity	1.88e-05	5.95e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—DRD2—obesity	1.87e-05	5.92e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MTHFR—obesity	1.87e-05	5.92e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—DPYD—obesity	1.86e-05	5.9e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GOT2—obesity	1.85e-05	5.87e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PTPN1—obesity	1.85e-05	5.86e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GCG—obesity	1.85e-05	5.86e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—TLR4—obesity	1.85e-05	5.84e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3R1—obesity	1.83e-05	5.79e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—FASN—obesity	1.81e-05	5.75e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—BCHE—obesity	1.81e-05	5.72e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PRKAR2B—obesity	1.79e-05	5.68e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—DCN—obesity	1.78e-05	5.63e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—IRS2—obesity	1.78e-05	5.63e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PRKCB—obesity	1.78e-05	5.63e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—ICAM1—obesity	1.77e-05	5.6e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PRL—obesity	1.77e-05	5.59e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—GOT2—obesity	1.76e-05	5.57e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—BAD—obesity	1.76e-05	5.56e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—obesity	1.75e-05	5.54e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CYP2E1—obesity	1.74e-05	5.52e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—STK11—obesity	1.74e-05	5.51e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—APOE—obesity	1.74e-05	5.51e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PIK3CB—obesity	1.73e-05	5.49e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CPT1A—obesity	1.73e-05	5.48e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—NQO1—obesity	1.72e-05	5.46e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CAV1—obesity	1.72e-05	5.46e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PLG—obesity	1.72e-05	5.45e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FASN—obesity	1.72e-05	5.45e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—APOA1—obesity	1.72e-05	5.44e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PTGS2—obesity	1.72e-05	5.44e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PARP1—obesity	1.71e-05	5.42e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NAMPT—obesity	1.7e-05	5.38e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—obesity	1.69e-05	5.34e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—obesity	1.69e-05	5.34e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GCK—obesity	1.69e-05	5.34e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—LIPC—obesity	1.69e-05	5.34e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IRS1—obesity	1.68e-05	5.32e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FOXO3—obesity	1.68e-05	5.32e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—APOC3—obesity	1.68e-05	5.31e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ADRB2—obesity	1.68e-05	5.31e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—obesity	1.67e-05	5.3e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—POMC—obesity	1.66e-05	5.27e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—SLC2A4—obesity	1.65e-05	5.23e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GCG—obesity	1.65e-05	5.23e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SOCS1—obesity	1.65e-05	5.23e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CYCS—obesity	1.63e-05	5.16e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SOCS3—obesity	1.63e-05	5.16e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CETP—obesity	1.63e-05	5.15e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—BAD—obesity	1.62e-05	5.13e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NOS1—obesity	1.61e-05	5.1e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SDC1—obesity	1.61e-05	5.1e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GOT1—obesity	1.6e-05	5.07e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GGT1—obesity	1.6e-05	5.07e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—obesity	1.6e-05	5.06e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GNB3—obesity	1.6e-05	5.05e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TCF7L2—obesity	1.59e-05	5.05e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—AKR1C3—obesity	1.58e-05	5.01e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—NCOA1—obesity	1.58e-05	4.99e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IGF2—obesity	1.57e-05	4.96e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SLC2A4—obesity	1.57e-05	4.96e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SCARB1—obesity	1.56e-05	4.94e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—AKT2—obesity	1.56e-05	4.93e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GNAS—obesity	1.55e-05	4.92e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CYP19A1—obesity	1.55e-05	4.92e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—STK11—obesity	1.55e-05	4.92e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—IRS1—obesity	1.55e-05	4.91e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—obesity	1.54e-05	4.87e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—APOB—obesity	1.52e-05	4.82e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—obesity	1.52e-05	4.81e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—GOT1—obesity	1.52e-05	4.8e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SREBF1—obesity	1.51e-05	4.79e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PIK3CD—obesity	1.49e-05	4.73e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PRL—obesity	1.49e-05	4.73e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCL5—obesity	1.49e-05	4.71e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—INS—obesity	1.49e-05	4.71e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GOT2—obesity	1.47e-05	4.66e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—LPL—obesity	1.45e-05	4.6e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—obesity	1.45e-05	4.6e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—COMT—obesity	1.44e-05	4.57e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FOXO1—obesity	1.44e-05	4.57e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—FASN—obesity	1.44e-05	4.56e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—RPS6KB1—obesity	1.44e-05	4.56e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—TYK2—obesity	1.44e-05	4.55e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—AKT2—obesity	1.44e-05	4.55e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—BCHE—obesity	1.43e-05	4.54e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GNB3—obesity	1.42e-05	4.51e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PPARGC1A—obesity	1.42e-05	4.51e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FOXO3—obesity	1.42e-05	4.5e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—HMOX1—obesity	1.42e-05	4.49e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PIK3R1—obesity	1.41e-05	4.47e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GNAS—obesity	1.39e-05	4.39e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP2E1—obesity	1.38e-05	4.38e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PIK3CD—obesity	1.38e-05	4.37e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NQO1—obesity	1.37e-05	4.33e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—SERPINE1—obesity	1.37e-05	4.32e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—PIK3CA—obesity	1.36e-05	4.32e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—BCL2—obesity	1.36e-05	4.3e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—APOB—obesity	1.36e-05	4.3e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IFNG—obesity	1.35e-05	4.26e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—obesity	1.34e-05	4.24e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PRKCD—obesity	1.34e-05	4.24e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TYK2—obesity	1.33e-05	4.2e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—RHOA—obesity	1.32e-05	4.17e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SLC2A4—obesity	1.31e-05	4.15e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GCG—obesity	1.31e-05	4.15e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HTR2A—obesity	1.31e-05	4.15e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PIK3CA—obesity	1.31e-05	4.15e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—C3—obesity	1.31e-05	4.14e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NOS3—obesity	1.3e-05	4.13e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PIK3R1—obesity	1.3e-05	4.13e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MTOR—obesity	1.3e-05	4.13e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PIK3CB—obesity	1.3e-05	4.13e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—LPL—obesity	1.3e-05	4.11e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYCS—obesity	1.29e-05	4.1e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APOB—obesity	1.29e-05	4.08e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GOT1—obesity	1.27e-05	4.02e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GGT1—obesity	1.27e-05	4.02e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GPX1—obesity	1.27e-05	4.01e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NCOA1—obesity	1.25e-05	3.96e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IRS2—obesity	1.24e-05	3.94e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AGT—obesity	1.24e-05	3.94e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—STK11—obesity	1.23e-05	3.91e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP19A1—obesity	1.23e-05	3.91e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CD36—obesity	1.23e-05	3.9e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—LPL—obesity	1.23e-05	3.89e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FOXO1—obesity	1.22e-05	3.86e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—LEP—obesity	1.22e-05	3.86e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—APOE—obesity	1.22e-05	3.86e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IL6—obesity	1.21e-05	3.82e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CAV1—obesity	1.21e-05	3.82e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—APOA1—obesity	1.2e-05	3.81e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PIK3CB—obesity	1.2e-05	3.81e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MTOR—obesity	1.2e-05	3.81e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL1B—obesity	1.2e-05	3.8e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PTGS2—obesity	1.19e-05	3.77e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—MTHFR—obesity	1.17e-05	3.7e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ESR1—obesity	1.16e-05	3.68e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PRKCB—obesity	1.15e-05	3.64e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—F2—obesity	1.15e-05	3.64e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—COMT—obesity	1.15e-05	3.63e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PPARA—obesity	1.15e-05	3.63e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—BAD—obesity	1.14e-05	3.59e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PRKCD—obesity	1.13e-05	3.59e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GNB3—obesity	1.13e-05	3.58e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PPARGC1A—obesity	1.13e-05	3.58e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—HMOX1—obesity	1.13e-05	3.56e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—AKT1—obesity	1.11e-05	3.53e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—AGT—obesity	1.11e-05	3.51e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MTHFR—obesity	1.11e-05	3.5e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MAPK8—obesity	1.1e-05	3.49e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GNAS—obesity	1.1e-05	3.49e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PIK3CG—obesity	1.1e-05	3.48e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—APOE—obesity	1.09e-05	3.44e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IRS1—obesity	1.09e-05	3.44e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—APOB—obesity	1.08e-05	3.41e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CAV1—obesity	1.08e-05	3.41e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—APOA1—obesity	1.07e-05	3.4e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—AKT1—obesity	1.07e-05	3.39e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PIK3CA—obesity	1.06e-05	3.35e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IRS2—obesity	1.05e-05	3.33e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—POMC—obesity	1.05e-05	3.31e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—INS—obesity	1.04e-05	3.3e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APOE—obesity	1.03e-05	3.26e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—LPL—obesity	1.03e-05	3.26e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.03e-05	3.26e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCL2—obesity	1.02e-05	3.24e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CAV1—obesity	1.02e-05	3.23e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APOA1—obesity	1.02e-05	3.23e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—STAT3—obesity	1.01e-05	3.19e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IGF1—obesity	1.01e-05	3.19e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AKT2—obesity	1.01e-05	3.18e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GPX1—obesity	1e-05	3.18e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PIK3CG—obesity	9.81e-06	3.11e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CD36—obesity	9.78e-06	3.1e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PIK3CD—obesity	9.66e-06	3.06e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—BAD—obesity	9.6e-06	3.04e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SERPINE1—obesity	9.56e-06	3.03e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PPARG—obesity	9.47e-06	3e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—POMC—obesity	9.34e-06	2.96e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TYK2—obesity	9.3e-06	2.94e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—STAT3—obesity	9.3e-06	2.94e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—INS—obesity	9.29e-06	2.94e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—MTHFR—obesity	9.27e-06	2.94e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—RHOA—obesity	9.22e-06	2.92e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IRS1—obesity	9.19e-06	2.91e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PIK3R1—obesity	9.13e-06	2.89e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NOS3—obesity	9.13e-06	2.89e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PPARA—obesity	9.09e-06	2.88e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—AGT—obesity	8.81e-06	2.79e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—INS—obesity	8.8e-06	2.79e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MYC—obesity	8.64e-06	2.74e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—AKT1—obesity	8.63e-06	2.73e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—APOE—obesity	8.63e-06	2.73e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PIK3CD—obesity	8.62e-06	2.73e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TGFB1—obesity	8.62e-06	2.73e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CAV1—obesity	8.55e-06	2.71e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—APOA1—obesity	8.53e-06	2.7e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ALB—obesity	8.51e-06	2.7e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—AKT2—obesity	8.51e-06	2.69e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PIK3CB—obesity	8.42e-06	2.67e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MTOR—obesity	8.42e-06	2.67e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PIK3CD—obesity	8.18e-06	2.59e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	8.17e-06	2.59e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PIK3R1—obesity	8.14e-06	2.58e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—NOS3—obesity	8.14e-06	2.58e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SERPINE1—obesity	8.09e-06	2.56e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PIK3CA—obesity	7.94e-06	2.51e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TYK2—obesity	7.86e-06	2.49e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—RHOA—obesity	7.8e-06	2.47e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PIK3CG—obesity	7.79e-06	2.47e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NOS3—obesity	7.72e-06	2.44e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PIK3R1—obesity	7.72e-06	2.44e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PIK3CB—obesity	7.52e-06	2.38e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PPARG—obesity	7.52e-06	2.38e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PTGS2—obesity	7.45e-06	2.36e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—POMC—obesity	7.41e-06	2.35e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—INS—obesity	7.37e-06	2.33e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PIK3CA—obesity	7.33e-06	2.32e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MMP9—obesity	7.32e-06	2.32e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MTOR—obesity	7.13e-06	2.26e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PIK3CB—obesity	7.13e-06	2.26e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MAPK8—obesity	7.12e-06	2.25e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL6—obesity	7.03e-06	2.23e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PIK3CD—obesity	6.85e-06	2.17e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ALB—obesity	6.76e-06	2.14e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—STAT3—obesity	6.51e-06	2.06e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—IL6—obesity	6.49e-06	2.06e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—AKT1—obesity	6.49e-06	2.05e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PIK3R1—obesity	6.46e-06	2.05e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NOS3—obesity	6.46e-06	2.05e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MYC—obesity	6.05e-06	1.92e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TGFB1—obesity	6.03e-06	1.91e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—AKT1—obesity	5.99e-06	1.9e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PIK3CB—obesity	5.97e-06	1.89e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—STAT3—obesity	5.51e-06	1.74e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PIK3CA—obesity	5.14e-06	1.63e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MYC—obesity	5.12e-06	1.62e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TGFB1—obesity	5.1e-06	1.62e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PIK3CA—obesity	4.58e-06	1.45e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL6—obesity	4.55e-06	1.44e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PIK3CA—obesity	4.34e-06	1.38e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AKT1—obesity	4.2e-06	1.33e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IL6—obesity	3.85e-06	1.22e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—AKT1—obesity	3.74e-06	1.19e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PIK3CA—obesity	3.64e-06	1.15e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—AKT1—obesity	3.55e-06	1.12e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—AKT1—obesity	2.97e-06	9.41e-06	CbGpPWpGaD
